Stephen P. Robertson is CLO & VP at Aurinia Pharmaceuticals Inc. (AUPH). They have made 7 open-market trades across 1 company since 2021, most recently 2026-09-10.
CIK 0001837798
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2021, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AUPH | 588,848 | $9.7M |
Shares reported on the most recent Form 4, priced at the 2026-09-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AUPH | SELL | 2026-09-10 | 2026-09-11 | $15.95 | $190K | +1.9% | +2.9% | — |
| AUPH | SELL | 2026-08-21 | 2026-08-25 | $16.97 | $356K | -3.3% | -0.2% | — |
| AUPH | SELL | 2025-03-03 | 2025-03-04 | $7.95 | $1.4M | +0.7% | -0.6% | -1.7% |
| AUPH | SELL | 2024-03-06 | 2024-03-07 | $5.60 | $323K | -5.1% | -8.8% | +0.0% |
| AUPH | SELL | 2023-03-02 | 2023-03-06 | $8.94 | $173K | +3.3% | +7.8% | +7.0% |
| AUPH | SELL | 2023-03-02 | 2024-02-22 | $8.78 | $345K | -6.0% | -16.3% | -7.2% |
| AUPH | BUY | 2021-01-28 | 2021-01-29 | $16.14 | $15K | -1.4% | -13.0% | -27.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.